Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Net Current Assets

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Current Assets (Including Current Investments) ₹14,670 Cr₹12,480 Cr₹11,573 Cr₹9,966 Cr₹9,888 Cr

What is the latest Net Current Assets ratio of AUROBINDO PHARMA ?

The latest Net Current Assets ratio of AUROBINDO PHARMA is ₹14,670 Cr based on Mar2026 Consolidated results.
Year Net Current Assets
Mar2026₹14,670 Cr
Mar2025₹12,480 Cr
Mar2024₹11,573 Cr
Mar2023₹9,966 Cr
Mar2022₹9,888 Cr

How is Net Current Assets of AUROBINDO PHARMA Trending?

Years Net Current Assets % Change
Mar2026 ₹14,670 Cr
17.54
Mar2025 ₹12,480 Cr
7.84
Mar2024 ₹11,573 Cr
16.12
Mar2023 ₹9,966 Cr
0.79
Mar2022 ₹9,888 Cr -

Compare Net Current Assets of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹95,573.9 Cr 4.4% 4.7% 39.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

4.4%

4.7%

39.3%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses